Subliminal laser therapy as a gold standard in treatment of central serous chorioretinopathy
Article Sidebar
Main Article Content
Abstract
Central serous chorioretinopathy occurs most commonly in young, professionally active people. Unfortunately, its exact pathogenesis remains unknown, so that causative treatment does not exist. There can be a spontaneous improvement in some cases but it takes usually a few months. The use of subthreshold laser therapy, called also micropulse therapy, in the acute form of the disease brings new options for an effective treatment. The faster resorption of subretinal fluid and shorter recuperation time is then observed. Micropulse laser therapy is a safe procedure that does not cause retinal scaring visible on clinical examination, OCT and fluorescein angiography
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Casella AM, Berbel RF, Bressanim GL et al. Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy. Clinics (Sao Paulo). 2012; 67(9): 1047-52.
3. Liu B, Deng T, Zhang J. Risk factors for central serous chorioretinopathy: A systematic review and Meta Analisys. Retina. 2016: 36(1): 9-19.
4. Cakir B, Fischer F, Ehlken C et al. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2016; 254(11): 2151-7.
5. Arsan A, Kanar HS, Sonmez A. Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up. Eye (Lond). 2018; 32(4): 726-33.
6. Scholz P, Ersoy L, Boon CJ et al. Subthreshold Micropulse Laser (577 nm) Treatment in Chronic Central Serous Chorioretinopathy. Ophthalmologica. 2015; 234: 189-94
7. Gawęcki M, Jaszczuk-Maciejewska A, Jurska-Jaśko A et al. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser. Graefes Arch Clin Exp Ophthalmol. 2017; 255: 2299-306.
8. Luttrull JK. Low-intensity/high-density subthreshold diode micropulse laser for central serous chorioretinopathy. Retina. 2015; 36: 1658-63.
9. Abd Elhamid AH. Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy. Clin Ophtalmol. 2015; 9: 2277-83.